31R and RVVTF Related Headlines

Go Back

Nov 21, 2025 12:07PM Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

31R and RVVTF Related Press Releases

Go Back

Nov 21, 2025 12:07PM Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

31R and RVVTF Related SEC Filings

Go Back